{"id":8151,"date":"2016-10-28T06:00:23","date_gmt":"2016-10-28T06:00:23","guid":{"rendered":"https:\/\/heliospectra.com\/blog\/mfn_news\/heliospectra-interim-management-statement-january-september-2016\/"},"modified":"2025-04-09T17:39:53","modified_gmt":"2025-04-09T17:39:53","slug":"heliospectra-interim-management-statement-january-september-2016","status":"publish","type":"mfn_news","link":"https:\/\/heliospectra.com\/nl\/blog\/mfn_nieuws\/heliospectra-interim-management-statement-january-september-2016\/","title":{"rendered":"Heliospectra Interim Management Statement January – September 2016"},"content":{"rendered":"
\n
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for controlled environments horticulture, presents today their Interim Management Statement for January – September 2016.<\/p>\n
Turnover and profit\/loss January – September<\/strong><\/p>\n Significant events <\/strong> April - juni<\/p>\n Juli - september<\/p>\n Events after the end of the period <\/strong><\/p>\n \n<\/div>\n Een woordje van de CEO <\/strong> The market for medicinal plants continues to develop rapidly. On top of the 23 states in the US where growing medicinal cannabis has been legalized, another handful are set to rule on this decision in the near future. In Australia it will be implemented by November according to a recent ruling1. We are observing a global trend. Turkey has recently ruled to legalize controlled production in 19 provinces2. Earlier this year Macedonia legalized use for medicinal purposes3. These types of discussions are going around many other European countries, where it is already possible to buy approved prescribed substances in pharmacies. We can see this same trend in Latin America, where Uruguay is one of the countries that has taken the lead.<\/p>\n There are a number of important driving forces behind Heliospectra’s technology. FAO4 recently stated that climate change related to farming is already considerable, while at the same time the demand for food will increase by at least 60% by 2050. We have a situation involving a growing population and increasing urbanization. To be able handle this situation the production methods need to be improved and concede to an increased level of automation. This also drives agricultural technology companies – who develop and sell seeds, pesticides and fertilizer – to invest in new technology. Furthermore, the actual production will have to take place closer to the consumer, which accelerates the growth of “city farming” and cuts down on logistical flows. We are counting on significant changes being made to the entire value chain in the years to come.<\/p>\n The company’s positive development continues. Compared to the same period last year we have increased our revenues by 160 %. We can also enjoy a testimony to the confidence our customers place in us when one of the world’s leading agricultural technology company places their fourth order for another 1.9 MSEK.<\/p>\n To continue to finance our expansion on the market, the company’s board has suggested a preferential rights issue of approx. 91MSEK, with the possibility of an over allocation of approx. 20MSEK. It is very positive that our principal owners support the company and have committed to subscribe, while also making sure that the entire rights issue is fully underwritten. The raised capital mainly relates to operating capital for sales and marketing, continued product development and to strengthen the balance sheet.<\/p>\n With rapidly growing markets, world leading products and strong principal owners backing us we can look positively to the future.<\/p>\n Staffan Hillberg, CEO 1) www.canberratimes.com.au\/act-news\/medicinal-cannabis-to-be-legalised-in-australia-from-november- 20160901-gr6kb5.html<\/a> Voor het volledige rapport: http:\/\/ir.heliospectra.com\/en\/financial-reports\/<\/a><\/p>\n For the complete Interim management statement, see attached document.<\/em><\/p>\n GOTHENBURG, Sweden\/SAN FRANCISCO, CA, October 28th, 2016<\/p>\n Investeerdersrelaties: <\/strong> Michael Swartz, Senior Analist | Viridian Capital Advisors, LLC | +1 212-333-0257 | G&W is Heliospectra's gecertificeerde adviseur voor Nasdaq First North. www.gwkapital.se<\/a> De volgende documenten kunnen worden opgehaald uit beQuoted <\/p>\n This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CEST on October 28th, 2016.<\/p>\n Over Heliospectra AB <\/strong> Heliospectra products are based on in-depth knowledge in plant physiology and photosynthesis along with a unique way to utilize modern LED technology. After six years of development in Sweden, the company has now begun to expand into the international market. The company has raised more than $ 21 million in capital and has received more than $2.6 million through academic scholarships and grants. It has also received numerous awards for its forward thinking technology. Largest shareholders: Weland Steel www.welandstal.se<\/a>, Zweeds Industrieel Fonds www.industrifonden.se<\/a>, Midroc www.midroc.se<\/a>, Avanza Pensioen www.avanza.se<\/a>.<\/p>\n Toekomstgerichte verklaringen <\/strong> <\/em><\/p>\n\n
Januari – March<\/p>\n\n
\n
\n
\n
Dear shareholders of Heliospectra AB (publ),<\/p>\n
Heliospectra AB (publ)<\/p>\n
2) www.independent.co.uk\/news\/world\/europe\/turkey-legalises-controlled-cannabis-production-19-provinces- a7364026.html <\/a>
3) www.balkaninsight.com\/en\/article\/macedonia-allows-medical-marijuana-in-pharmacies-05-31-2016<\/a>
4) www.fao.org\/publications\/sofa\/en\/?utm_source=faohomepage&utm_medium=web&utm_campaign=featurebar<\/a><\/p>\n
Staffan Hillberg, CEO of Heliospectra |
+46 (0)708 36 59 44
staffan.hillberg@heliospectra.com <\/a><\/p>\n
mswartz@viridianca.com<\/a><\/p>\n
www.heliospectra.com<\/a><\/p>\n
Heliospectra Pressrelease 2016-10-28 English.pdf<\/a>
Heliospectra Interim Management Statement Q3 2016.pdf<\/a><\/p>\n
Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO) (www.heliospectra.com<\/a>) is gespecialiseerd in intelligente verlichtingstechnologie voor plantenonderzoek en kassenteelt. Het verlichtingssysteem van het bedrijf biedt een effectieve en duurzame technologie voor het kweken van kas- en kamerplanten door verschillende groepen veelzijdige lichtgevende diodes (LED's) te combineren met optiek, remote sensing-technieken en een robuuste warmteafvoeroplossing. Deze gepatenteerde opstelling geeft kwekers de mogelijkheid om de intensiteit en golflengten van het uitgestraalde licht te regelen, waardoor een spectrum wordt gecre\u00eberd dat specifiek is aangepast aan verschillende plantensoorten en groeistadia om de fotosynthese beter te bevorderen. De complete, geavanceerde lamp produceert gewassen die er beter uitzien, beter smaken en langer houdbaar zijn dan gewassen die met HID-lampen worden gekweekt. De technologie verlaagt niet alleen het energieverbruik met wel 50%, maar helpt ook groeikenmerken te stimuleren en de kwaliteit van de plant te verbeteren. Andere voordelen zijn minder lichtvervuiling, minder kwikverbruik door het vermijden van traditionele HID\/HPS-lampen en minder HVAC-investeringen en maandelijkse kosten.<\/p>\n
De verklaringen in dit persbericht zijn toekomstgerichte verklaringen zoals bedoeld in de federale effectenwetgeving. Dergelijke verklaringen zijn gebaseerd op onze huidige overtuigingen en verwachtingen en zijn inherent onderhevig aan belangrijke zakelijke, economische en concurrerende onzekerheden en onvoorziene omstandigheden, waarvan vele buiten onze macht liggen. Daarnaast zijn dergelijke toekomstgerichte uitspraken onderhevig aan aannames met betrekking tot toekomstige bedrijfsstrategie\u00ebn en beslissingen die aan verandering onderhevig zijn. Potenti\u00eble risico's en onzekerheden omvatten, maar zijn niet beperkt tot, technische vooruitgang in de sector en politieke en economische omstandigheden in de sector. We nemen geen verplichting op ons om toekomstgerichte uitspraken bij te werken om gebeurtenissen of ontwikkelingen weer te geven nadat een toekomstgerichte uitspraak is gedaan.<\/p>\n